95 related articles for article (PubMed ID: 12140768)
1. bcl-xL and RAG genes are induced and the response to IL-2 enhanced in EmuEBNA-1 transgenic mouse lymphocytes.
Tsimbouri P; Drotar ME; Coy JL; Wilson JB
Oncogene; 2002 Aug; 21(33):5182-7. PubMed ID: 12140768
[TBL] [Abstract][Full Text] [Related]
2. Epstein-Barr virus nuclear antigen-1 renders lymphocytes responsive to IL-2 but not IL-15 for survival.
Tsimbouri P; Al-Sheikh Y; Drotar ME; Cushley W; Wilson JB
J Gen Virol; 2008 Nov; 89(Pt 11):2821-2832. PubMed ID: 18931080
[TBL] [Abstract][Full Text] [Related]
3. Regulation of cell survival during B lymphopoiesis: apoptosis and Bcl-2/Bax content of precursor B cells in bone marrow of mice with altered expression of IL-7 and recombinase-activating gene-2.
Lu L; Chaudhury P; Osmond DG
J Immunol; 1999 Feb; 162(4):1931-40. PubMed ID: 9973461
[TBL] [Abstract][Full Text] [Related]
4. Cellular target genes of Epstein-Barr virus nuclear antigen 2.
Maier S; Staffler G; Hartmann A; Höck J; Henning K; Grabusic K; Mailhammer R; Hoffmann R; Wilmanns M; Lang R; Mages J; Kempkes B
J Virol; 2006 Oct; 80(19):9761-71. PubMed ID: 16973580
[TBL] [Abstract][Full Text] [Related]
5. Epstein-Barr virus nuclear antigen-1 and Myc cooperate in lymphomagenesis.
Drotar ME; Silva S; Barone E; Campbell D; Tsimbouri P; Jurvansu J; Bhatia P; Klein G; Wilson JB
Int J Cancer; 2003 Sep; 106(3):388-95. PubMed ID: 12845679
[TBL] [Abstract][Full Text] [Related]
6. Direct and indirect regulation of cytokine and cell cycle proteins by EBNA-2 during Epstein-Barr virus infection.
Spender LC; Cornish GH; Rowland B; Kempkes B; Farrell PJ
J Virol; 2001 Apr; 75(8):3537-46. PubMed ID: 11264343
[TBL] [Abstract][Full Text] [Related]
7. IL-6 rescues the hyporesponsiveness of c-Rel deficient B cells independent of Bcl-xL, Mcl-1, and Bcl-2.
Tumang JR; Hsia CY; Tian W; Bromberg JF; Liou HC
Cell Immunol; 2002; 217(1-2):47-57. PubMed ID: 12426000
[TBL] [Abstract][Full Text] [Related]
8. Bcl-2 reduces lymphomagenesis in deltaV-TCRbeta transgenic mice.
Acton D; Jacobs H; Domen J; Berns A
Oncogene; 1997 May; 14(21):2497-501. PubMed ID: 9191049
[TBL] [Abstract][Full Text] [Related]
9. Epstein-Barr virus (EBV) nuclear antigen 6 induces expression of the EBV latent membrane protein and an activated phenotype in Raji cells.
Allday MJ; Crawford DH; Thomas JA
J Gen Virol; 1993 Mar; 74 ( Pt 3)():361-9. PubMed ID: 8383171
[TBL] [Abstract][Full Text] [Related]
10. Bcl-2 overexpression leads to increases in suppressor of cytokine signaling-3 expression in B cells and de novo follicular lymphoma.
Vanasse GJ; Winn RK; Rodov S; Zieske AW; Li JT; Tupper JC; Tang J; Raines EW; Peters MA; Yeung KY; Harlan JM
Mol Cancer Res; 2004 Nov; 2(11):620-31. PubMed ID: 15561778
[TBL] [Abstract][Full Text] [Related]
11. The latency pattern of Epstein-Barr virus infection and viral IL-10 expression in cutaneous natural killer/T-cell lymphomas.
Xu ZG; Iwatsuki K; Oyama N; Ohtsuka M; Satoh M; Kikuchi S; Akiba H; Kaneko F
Br J Cancer; 2001 Apr; 84(7):920-5. PubMed ID: 11286472
[TBL] [Abstract][Full Text] [Related]
12. IL-7 reconstitutes multiple aspects of v-Abl-mediated signaling.
Banerjee A; Rothman P
J Immunol; 1998 Nov; 161(9):4611-7. PubMed ID: 9794389
[TBL] [Abstract][Full Text] [Related]
13. Tumor necrosis factor prevents alendronate-induced osteoclast apoptosis in vivo by stimulating Bcl-xL expression through Ets-2.
Zhang Q; Badell IR; Schwarz EM; Boulukos KE; Yao Z; Boyce BF; Xing L
Arthritis Rheum; 2005 Sep; 52(9):2708-18. PubMed ID: 16142752
[TBL] [Abstract][Full Text] [Related]
14. Expression of LMP and EBNA genes in Epstein-Barr virus-associated lymphomas in Hu-PBL/SCID mice.
Tang Y; Lu S; Gan X; Liu F; Zhang Y; Luo C; Pan Y; Hong L; Gan R
Oncol Rep; 2016 Feb; 35(2):905-11. PubMed ID: 26548532
[TBL] [Abstract][Full Text] [Related]
15. Epstein-Barr virus nuclear antigen 2 trans-activates the cellular antiapoptotic bfl-1 gene by a CBF1/RBPJ kappa-dependent pathway.
Pegman PM; Smith SM; D'Souza BN; Loughran ST; Maier S; Kempkes B; Cahill PA; Simmons MJ; Gélinas C; Walls D
J Virol; 2006 Aug; 80(16):8133-44. PubMed ID: 16873269
[TBL] [Abstract][Full Text] [Related]
16. Targeted overexpression of Bcl-XL in B-lymphoid cells results in lymphoproliferative disease and plasma cell malignancies.
Linden M; Kirchhof N; Carlson C; Van Ness B
Blood; 2004 Apr; 103(7):2779-86. PubMed ID: 14656874
[TBL] [Abstract][Full Text] [Related]
17. Simultaneous detection of the two main proliferation driving EBV encoded proteins, EBNA-2 and LMP-1 in single B cells.
Rasul AE; Nagy N; Sohlberg E; Ádori M; Claesson HE; Klein G; Klein E
J Immunol Methods; 2012 Nov; 385(1-2):60-70. PubMed ID: 22921685
[TBL] [Abstract][Full Text] [Related]
18. Type I interferons directly down-regulate BCL-6 in primary and transformed germinal center B cells: differential regulation in B cell lines derived from endemic or sporadic Burkitt's lymphoma.
Salamon D; Adori M; He M; Bönelt P; Severinson E; Kis LL; Wu L; Ujvari D; Leveau B; Nagy N; Klein G; Klein E
Cytokine; 2012 Mar; 57(3):360-71. PubMed ID: 22204827
[TBL] [Abstract][Full Text] [Related]
19. The apoptosis and proliferation of SAC-activated B cells by IL-10 are associated with changes in Bcl-2, Bcl-xL, and Mcl-1 expression.
Li L; Krajewski S; Reed JC; Choi YS
Cell Immunol; 1997 May; 178(1):33-41. PubMed ID: 9184696
[TBL] [Abstract][Full Text] [Related]
20. Overexpression of Bcl-2 or Bcl-XL transgenes and photoreceptor degeneration.
Joseph RM; Li T
Invest Ophthalmol Vis Sci; 1996 Nov; 37(12):2434-46. PubMed ID: 8933760
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
